tirzepatide effect on kidneys The benefits and risks of in various metabolic diseases Interplay of Chronic Kidney Disease

[DOI] [PubMed] [Google Scholar] 44.Hiu JJ, Yap MKK

Abstract Importance Semaglutide and tirzepatide, the new generation of glucagon-like peptide-1 receptor agonist used to treat type 2 diabetes and obesity, were recently reported to be associated with increased risk of nonarteritic anterior ischemic optic neuropathy (NAION)

A provider may recommend upward dose titration, extended dosing intervals, or alternative formulations (oral vs

Efficacy of ketogenic diet on body composition during resistance training in trained men: A randomized controlled trial

These reductions were observed across different BMI ranges, making the pill a potential option for a broad set of adults with obesity